Recent News

567 News Items found
Montage of beer, reproducing cells, and building blocks
Feature
MSK researchers are rethinking the relationship between metabolism and cancer, and finding insights in some unexpected places. Your beer glass, for example.
Microscopic image of spherical cluster of cells, most of them pink cells with a smaller number of blue ones.
Feature
MSK researchers moved cancer science ahead in 2015 with landmark discoveries that suggest new treatment strategies and shed light on how the disease progresses.
Researchers at MSK have devised a technique, based on machine learning, that can predict the DNA binding preferences of a protein called a transcription factor.
In the Lab
Computers currently help us choose our favorite movies, books, and TV shows. Will personalized medicines be next?
Kenneth Offit
In the Clinic
MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.
A scientist pictured in his lab
Announcement
The awards are given annually to people in an array of fields in the arts and sciences.
Hyperpolarized MRI
In the Clinic
Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Test tubes and glass vials and beakers sit on a desk in a laboratory.
In the Lab
A new Sloan Kettering Institute program will enhance the use of chemical principles to investigate biological processes.
Organoid cell structures fluorescing in blue, green, and purple.
In the Lab
For the first time, scientists have shown that the gene APC, which is mutated in the vast majority of colorectal cancers, might be a promising target for future therapies.
Proximal tubule of the kidney.
In the Lab
Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs.
MSK investigators Joan Massagué and Anna Obenauf
In the Lab
Outsmarting Cancer’s Survival Skills
A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.